[Biotech&Pharma] The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data

Browse By

Here's a roundup of top developments in the biotech space over the last 24 hours.

Scaling The Peaks

(Biotech Stocks Hitting 52-week highs on Feb. 11)

  • AbbVie Inc (NYSE: ABBV)
  • Acceleron Pharma Inc (NASDAQ: XLRN)
  • Agile Therapeutics Inc (NASDAQ: AGRX)(announced securing of loan facility)
  • Allergan plc (NYSE: AGN)
  • Akebia Therapeutics Inc (NASDAQ: AKBA)
  • Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)
  • Ascendis Pharma A/S (NASDAQ: ASND)
  • AtriCure Inc. (NASDAQ: ATRC)
  • ChemoCentryx Inc (NASDAQ: CCXI)
  • Cue Biopharma Inc (NASDAQ: CUE)
  • Cytokinetics, Inc. (NASDAQ: CYTK)
  • Deciphera Pharmaceuticals Inc (NASDAQ: DCPH)
  • DexCom, Inc. (NASDAQ: DXCM)
  • Esperion Therapeutics Inc (NASDAQ: ESPR)
  • Fulgent Genetics Inc (NASDAQ: FLGT)
  • Insulet Corporation (NASDAQ: PODD)
  • Masimo Corporation (NASDAQ: MASI)
  • Medpace Holdings Inc (NASDAQ: MEDP)
  • Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA)
  • Nevro Corp (NYSE: NVRO)
  • Novartis AG (NYSE: NVS)(announced priority review for its lung cancer drug)
  • Pacira Biosciences Inc (NASDAQ: PCRX)
  • PAVmed Inc (NASDAQ: PAVM)(PAVmed's EsoGuard Esophageal DNA test was accorded Breakthrough Device designation)
  • Penumbra Inc (NYSE: PEN)
  • Principia Biopharma Inc (NASDAQ: PRNB)
  • PTC Therapeutics, Inc (NASDAQ: PTCT)
  • Seattle Genetics, Inc. (NASDAQ: SGEN)(announced positive data readout for ADC in bladder cancer)
  • Syneos Health Inc (NASDAQ: SYNH)
  • Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)
  • West Pharmaceutical Services Inc. (NYSE: WST)
  • Zai Lab Ltd (NASDAQ: ZLAB)
  • Zoetis Inc (NYSE: ZTS)

Down In The Dumps

(Biotech Stocks Hitting 52-week lows on Feb. 11)

  • Brickell Biotech Inc (NASDAQ: BBI)
  • Endologix, Inc. (NASDAQ: ELGX)
  • Enzo Biochem, Inc. (NYSE: ENZ)( received New York State approval for its gynecological …

Full story available on Benzinga.com

Source Benzinga

Disclaimer: All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. The author is not paid to share this information. Cannabis Investment Group is not paid to share this information and has no business relationship other than shareholder with any company whose stock is mentioned in this article.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.